Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Golexanolone by Umecrine Cognition for Hepatic Encephalopathy: Likelihood of Approval
Golexanolone is under clinical development by Umecrine Cognition and currently in Phase II for Hepatic Encephalopathy. According to GlobalData, Phase...
Data Insights
Golexanolone by Umecrine Cognition for Idiopathic Hypersomnia (IH): Likelihood of Approval
Golexanolone is under clinical development by Umecrine Cognition and currently in Phase II for Idiopathic Hypersomnia (IH). According to GlobalData,...